197 related articles for article (PubMed ID: 20659916)
1. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.
Mikuls TR; Fay BT; Michaud K; Sayles H; Thiele GM; Caplan L; Johnson D; Richards JS; Kerr GS; Cannon GW; Reimold A
Rheumatology (Oxford); 2011 Jan; 50(1):101-9. PubMed ID: 20659916
[TBL] [Abstract][Full Text] [Related]
2. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.
England BR; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer BC; Solow EB; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):36-45. PubMed ID: 26097231
[TBL] [Abstract][Full Text] [Related]
3. Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival.
England BR; Sayles H; Michaud K; Thiele GM; Poole JA; Caplan L; Sauer BC; Cannon GW; Reimold A; Kerr GS; Baker JF; Mikuls TR
Clin Rheumatol; 2018 Nov; 37(11):2907-2915. PubMed ID: 30280369
[TBL] [Abstract][Full Text] [Related]
4. Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.
Cannon GW; Mikuls TR; Hayden CL; Ying J; Curtis JR; Reimold AM; Caplan L; Kerr GS; Richards JS; Johnson DS; Sauer BC
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1680-90. PubMed ID: 21905260
[TBL] [Abstract][Full Text] [Related]
5. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
6. Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.
Krause C; Herborn G; Braun J; Rudolf H; Wassenberg S; Rau R; Krause D
Clin Exp Rheumatol; 2017; 35(3):384-389. PubMed ID: 27974101
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
9. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.
Masamoto K; Otsuki B; Fujibayashi S; Shima K; Ito H; Furu M; Hashimoto M; Tanaka M; Lyman S; Yoshitomi H; Tanida S; Mimori T; Matsuda S
Eur Spine J; 2018 Feb; 27(2):406-415. PubMed ID: 29185111
[TBL] [Abstract][Full Text] [Related]
11. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
12. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis.
Krause D; Schleusser B; Herborn G; Rau R
Arthritis Rheum; 2000 Jan; 43(1):14-21. PubMed ID: 10643695
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1 Haplotypes, Shared Epitope, and Disease Outcomes in US Veterans with Rheumatoid Arthritis.
Zhao M; Mauer L; Sayles H; Cannon GW; Reimold A; Kerr GS; Baker JF; Thiele GM; England BR; Mikuls TR
J Rheumatol; 2019 Jul; 46(7):685-693. PubMed ID: 30824656
[TBL] [Abstract][Full Text] [Related]
14. Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Johnson TM; Sayles HR; Baker JF; George MD; Roul P; Zheng C; Sauer B; Liao KP; Anderson DR; Mikuls TR; England BR
Ann Rheum Dis; 2021 Nov; 80(11):1385-1392. PubMed ID: 34049859
[TBL] [Abstract][Full Text] [Related]
15. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
16. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
17. Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Baker JF; England BR; George M; Cannon G; Sauer B; Ogdie A; Hamilton BC; Hunter C; Duryee MJ; Thiele G; Mikuls TR
Ann Rheum Dis; 2021 May; 80(5):566-572. PubMed ID: 33397733
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate.
Rathbun AM; England BR; Mikuls TR; Ryan AS; Barton JL; Shardell MD; Hochberg MC
J Rheumatol; 2021 Jun; 48(6):813-820. PubMed ID: 33191277
[TBL] [Abstract][Full Text] [Related]
19. Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.
Rodriguez-Rodriguez L; Leon L; Ivorra-Cortes J; Gómez A; Lamas JR; Pato E; Jover JÁ; Abásolo L
Clin Exp Rheumatol; 2016; 34(6):1026-1032. PubMed ID: 27749239
[TBL] [Abstract][Full Text] [Related]
20. Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands.
Matthijssen XME; Niemantsverdriet E; Huizinga TWJ; van der Helm-van Mil AHM
PLoS Med; 2020 Sep; 17(9):e1003296. PubMed ID: 32960885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
